tiprankstipranks
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
US Market
WST
West Pharmaceutical Services
RESEARCH TOOLSreports
Want to see WST full AI Analyst Report?

West Pharmaceutical Services (WST) Ratios

893 Followers

West Pharmaceutical Services Ratios

WST's free cash flow for Q1 2026 was $0.35. For the 2026 fiscal year, WST's free cash flow was decreased by $ and operating cash flow was $0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.71 3.02 2.79 2.88 3.70
Quick Ratio
 2.04 2.34 2.11 2.24 2.90
Cash Ratio
 0.77 1.21 0.88 1.27 1.72
Solvency Ratio
 0.60 0.56 0.67 0.77 0.76
Operating Cash Flow Ratio
 1.06 1.15 1.19 1.16 1.39
Short-Term Operating Cash Flow Coverage
 33.43 33.25 34.76 5.79 329.09
Net Current Asset Value
$ 707.40M$ 884.20M$ 577.00M$ 987.90M$ 987.60M
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.10 0.08 0.08 0.09
Debt-to-Equity Ratio
 0.11 0.13 0.11 0.11 0.12
Debt-to-Capital Ratio
 0.10 0.12 0.10 0.10 0.11
Long-Term Debt-to-Capital Ratio
 0.09 0.09 0.07 0.02 0.07
Financial Leverage Ratio
 1.37 1.34 1.36 1.33 1.35
Debt Service Coverage Ratio
 30.41 25.84 29.32 5.05 70.76
Interest Coverage Ratio
 3.33K 1.03K 205.03 80.78 100.46
Debt to Market Cap
 0.01 0.02 <0.01 <0.01 0.01
Interest Debt Per Share
 4.39 5.77 4.22 4.28 4.38
Net Debt to EBITDA
 -0.26 -0.52 -0.24 -0.65 -0.71
Profitability Margins
Gross Profit Margin
36.24%35.89%34.65%38.38%39.47%
EBIT Margin
20.73%19.49%20.34%23.95%23.83%
EBITDA Margin
24.81%23.54%25.71%28.60%28.01%
Operating Profit Margin
20.67%20.09%20.56%24.09%26.46%
Pretax Profit Margin
21.16%20.02%20.75%24.25%24.28%
Net Profit Margin
16.85%16.06%17.03%20.11%20.30%
Continuous Operations Profit Margin
16.75%16.06%17.03%20.11%20.30%
Net Income Per EBT
79.63%80.24%82.09%82.91%83.63%
EBT Per EBIT
102.39%99.66%100.94%100.68%91.76%
Return on Assets (ROA)
13.21%11.56%13.52%15.50%16.20%
Return on Equity (ROE)
17.87%15.54%18.37%20.60%21.82%
Return on Capital Employed (ROCE)
19.37%17.08%19.22%22.51%24.65%
Return on Invested Capital (ROIC)
15.24%13.62%15.69%17.81%20.49%
Return on Tangible Assets
13.59%11.89%13.97%16.01%16.78%
Earnings Yield
2.58%2.48%2.06%2.27%3.35%
Efficiency Ratios
Receivables Turnover
 4.70 5.35 5.24 5.76 5.69
Payables Turnover
 8.14 7.77 7.90 7.50 8.11
Inventory Turnover
 4.54 4.44 5.01 4.18 4.21
Fixed Asset Turnover
 0.97 0.00 1.72 1.95 2.29
Asset Turnover
 0.78 0.72 0.79 0.77 0.80
Working Capital Turnover Ratio
 2.60 2.66 2.57 2.21 2.26
Cash Conversion Cycle
 113.31 103.44 96.30 101.93 105.85
Days of Sales Outstanding
 77.71 68.21 69.71 63.33 64.18
Days of Inventory Outstanding
 80.45 82.23 72.79 87.26 86.68
Days of Payables Outstanding
 44.85 47.00 46.20 48.66 45.01
Operating Cycle
 158.16 150.44 142.50 150.58 150.87
Cash Flow Ratios
Operating Cash Flow Per Share
 9.93 10.44 8.95 10.45 9.73
Free Cash Flow Per Share
 6.36 6.49 3.79 5.58 5.91
CapEx Per Share
 3.57 3.95 5.16 4.87 3.83
Free Cash Flow to Operating Cash Flow
 0.64 0.62 0.42 0.53 0.61
Dividend Paid and CapEx Coverage Ratio
 2.24 2.17 1.50 1.85 2.14
Capital Expenditure Coverage Ratio
 2.78 2.64 1.73 2.15 2.54
Operating Cash Flow Coverage Ratio
 2.26 1.81 2.14 2.51 2.28
Operating Cash Flow to Sales Ratio
 0.22 0.25 0.23 0.26 0.25
Free Cash Flow Yield
2.22%2.36%1.16%1.58%2.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 40.62 40.29 48.53 44.09 29.89
Price-to-Sales (P/S) Ratio
 6.72 6.47 8.27 8.87 6.07
Price-to-Book (P/B) Ratio
 7.37 6.26 8.91 9.08 6.52
Price-to-Free Cash Flow (P/FCF) Ratio
 47.23 42.42 86.51 63.12 39.85
Price-to-Operating Cash Flow Ratio
 30.82 26.35 36.60 33.69 24.19
Price-to-Earnings Growth (PEG) Ratio
 2.37 34.00 -3.13 31.58 -2.61
Price-to-Fair Value
 7.37 6.26 8.91 9.08 6.52
Enterprise Value Multiple
 26.81 26.97 31.91 30.35 20.95
Enterprise Value
 20.43B 19.52B 23.73B 25.62B 16.93B
EV to EBITDA
 25.57 26.97 31.91 30.35 20.95
EV to Sales
 6.34 6.35 8.20 8.68 5.87
EV to Free Cash Flow
 44.61 41.63 85.86 61.80 38.54
EV to Operating Cash Flow
 28.57 25.86 36.32 32.99 23.39
Tangible Book Value Per Share
 39.92 42.30 35.14 37.11 34.40
Shareholders’ Equity Per Share
 41.53 43.93 36.74 38.78 36.09
Tax and Other Ratios
Effective Tax Rate
 0.21 0.20 0.18 0.17 0.16
Revenue Per Share
 44.73 42.51 39.63 39.72 38.78
Net Income Per Share
 7.54 6.83 6.75 7.99 7.88
Tax Burden
 0.80 0.80 0.82 0.83 0.84
Interest Burden
 1.02 1.03 1.02 1.01 1.02
Research & Development to Revenue
 0.02 0.02 0.02 0.02 0.02
SG&A to Revenue
 0.13 0.13 0.12 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.32 1.53 1.33 1.31 1.24
Currency in USD